February 2, 2012
SAN DIEGO, Sequenom, Inc. today announced that a new publication of an independent multi-center study on Sequenom Center for Molecular Medicine's MaterniT21™ laboratory-developed test (LDT) appears today in the online issue of Genetics in Medicine. The study demonstrated the LDT can detect fetal trisomy 21, 18 and 13 with high accuracy from a maternal blood [...]
PerkinElmer Announces Financial Results for the Fourth Quarter of 2011
February 2, 2012
WALTHAM, Mass. - PerkinElmer, Inc. PKI -0.57% , a global leader focused on improving the health and safety of people and the environment, today reported financial results for the fourth quarter ended January 1, 2012. The Company reported a GAAP loss per share from continuing operations of $0.75, as compared to earnings per share of [...]
SPRIworks HT from Beckman Coulter Automates Sample Preparation for Next Generation Sequencing,
February 2, 2012
BREA, CALIF.- Beckman Coulter Life Sciences will launch SPRIworks HT*, a high-throughput solution for fragment library preparation on Illumina next generation sequencers, at SLAS2012, which convenes Feb. 4-8 in San Diego. The system, which will be displayed at the conference in booth 619, allows researchers to process libraries with greater speed and sample reproducibility and [...]
Integromics partners with FPGMX to develop low-cost methods for clinical genomics
February 2, 2012
Granada and Madrid, Spain and Philadelphia, PA, U.S., Integromics®, a market leader in IT solutions provision for life sciences in the field of genomics and proteomics, today announces it has entered into a partnership with Professor Carracedo and his team at the Galician Foundation of Genomic Medicine (FPGMX), a recipient of the European Life Technologies [...]
Precision BioSciences Announces Allowance of Fourth U.S. Patent Related to Engineered Meganucleases
February 2, 2012
RESEARCH TRIANGLE PARK, N.C.- Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a Notice of Allowance for U.S. Patent Application 13/246,380 (“the '380 Application”). The allowed claims relate to an array of genome engineering methods, including the use of [...]
February 2, 2012
AUSTIN, Texas - Asuragen, Inc. announced today it has been appointed a Certified Service Provider (CSP) by Life Technologies (NASDAQ: LIFE) for Ion Torrent’s Personal Genome Machine (PGM). The Ion Torrent CSP Program is designed to assure customers that Asuragen has been trained and tested by Ion Torrent in the use of its semiconductor sequencing [...]
February 2, 2012
LEXINGTON, Mass., T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the issuance of patent number 8,102,176 by the United States Patent and Trademark Office entitled "NMR Device for Detection of Analytes". The patent broadly covers devices and methods of detecting analytes through magnetic resonance measurement, the basis for T2 Bio's [...]
February 2, 2012
San Dimas, CA - CRAIC Technologies, Inc., the world’s leading innovator of UV-visible-NIR micro-analysis solutions, has set a new standard for customer care in the scientific instrument world with the introduction of its Scientific Concierge Service™. Offered to CRAIC Technologies customers and prospective customers, the Scientific Concierge Services™ is staffed with a dedicated and experienced [...]
Morpho Detection Receives TSA Delivery Order for 15 CTX Explosives Detection Systems
February 2, 2012
NEWARK, Calif.- Morpho Detection, Inc. (MDI), the explosives and narcotics detection business of Morpho, Safran group's security unit, today announced it has received a delivery order under a U.S. Transportation Security Administration (TSA) new equipment contract for its CTX 9800 DSi(TM) and CTX 9400 DSi(TM) explosives detection systems (EDS) valued at more than $17 million. [...]
Ronnie Andrews Joins Life Technologies as President, Medical Sciences
February 2, 2012
CARLSBAD, Calif. -- Life Technologies Corporation today announced that Ronnie Andrews, former CEO of Clarient and Segment Leader, GE Molecular Diagnostics, has joined the company as President, Medical Sciences. Andrews has more than 25 years of experience in the diagnostics industry, including leadership positions at companies such as Abbott Diagnostics and Roche Diagnostics. As President, [...]
